Over three quarters of a sample of 150 videos on prostate cancer available on YouTube contain potentially misleading and/or biased content in the video itself or in the comments section, new research ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
Newswise — The most popular YouTube videos on prostate cancer often offer misleading or biased medical information that poses potential health risks to patients, an analysis of the social media ...
The PSA launches as Mount Sinai researchers begin EXPAND-PC, a five-year, $4.2 million project funded by the National Institutes of Health (NIH) to develop and evaluate a community-based approach to ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
PROTEUS met its amended co-primary end points but should not be interpreted as practice changing. The trial compared two experimental strategies rather than the current standard of care, relied on an ...
Prostate cancer will affect the lives of 1 in 8 men, often occurring later in life when patients are dealing with other challenging health conditions, such as arthritis or chronic obstructive ...
If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results